The announced pricing of a 5 day course of Paxlovid to the commercial market is $1380, announced a few days ago. The price charged to the US government had been about $550. I wonder what the co-pay for the consumer will be. It's unclear at the moment. There will be the usual wrangling by health insurance companies to lower the price a bit, perhaps. The drug isn't rationed here, but due to the byzantine health care system that leaves too many people without one, the effect may be one of rationing due to cost of the co-insurance, or no insurance.
I have a traditional Medicare plan with a Plan G supplement and a Humana drug plan. I got Paxlovid about 6 weeks ago to have on hand for traveling, and there was no charge. When I got Paxlovid last November, there was no charge, either. I hope this remains the case for my insurance.
Some info about US access to Paxlovid https://www.hhs.gov/about/news/2023...t-to-increase-patient-access-to-paxlovid.html